Skip to Main ContentSkip to Footer

Hematology Clinical Trials Program

The Hematology Clinical Trials Program at Monroe Carell allows children with blood disorders and their families to participate in national and international research studies. If your child is eligible for a study, you can help improve our understanding of hematologic disorders. This can determine the best treatments for your child and other patients.

Our clinical trials include studies that investigate the cause, development and effects of hematologic disorders. We also pursue studies to improve population health and to discover new treatment options for our patients.

Meet Your Care Team

Michael R. DeBaun

Michael R. DeBaunMD, MPH

    Division of Pediatric Hematology/Oncology, Pediatric Hematology/Oncology, Sickle Cell Disease
Heather L. McDaniel
4.8

Heather L. McDanielMD, MSCI

    General Hematology and Oncology, Hemostasis and Thrombosis, Pediatric Hematology/Oncology
Jennifer A. Murdock

Jennifer A. MurdockMD

    Blood Banking and Transfusion Medicine
Emmanuel J. Volanakis
4.9

Emmanuel J. VolanakisMD

    Pediatric Hematology/Oncology, Sickle Cell Disease

Why Choose Care at the Vanderbilt Hematology Clinical Trials Program

  • diploma, award, ribbon, Recognized care, quality
    Recognized care

    Vanderbilt offers a nationally recognized, federally funded Hemophilia Treatment Center (HTC) that can aid in clinical support for our patients throughout research trials. Our research team, including research nurses, data specialists and other support staff, chooses studies that will not only benefit the HTC community, but will also provide up-to-date and novel treatment options for patients who choose to participate.

  • health, circle, cross, Comprehensive care
    Comprehensive care

    Our comprehensive program for children with clotting disorders coordinates care with our other subspecialty care teams. We aim to improve anticoagulation safety and options for your child.

  • diploma, award, ribbon, Recognized care, quality
    Sickle Cell Center of Excellence

    The Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease is a federally funded program and a national leader in sickle cell treatment and research. We participate in both national and international studies aimed to improve our understanding of Sickle Cell Disease and improve treatment options for your child.

  • caduceus, Depth of expertise, excellent outcomes
    Increasing options

    As our program grows, we will continue providing more options to improve our understanding of pediatric hematologic disease, as well as treatment options for your child.

Location

2200 Children's Way, 6th Floor
Nashville, TN 37232
Today's hours:8:00 a.m. – 4:30 p.m.